• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

autoimmune disease

Hundred dollar bills wrapped with a red bow under a Christmas tree
Biotech

Pfizer, Sanofi round out '25 with separate autoimmune deals

As 2025 closes out, two biotechs have eked out separate deals with Big Pharma before year-end, each with a sizable potential payout down the line.
Fraiser Kansteiner Dec 15, 2025 11:06am
Photo of someone standing on a rock looking off to the left using binoculars

Sanofi, GSK ink preclinical pacts in hunt for new antibodies

Dec 10, 2025 11:15am
Space warp travel through universe

Formation Bio makes $605M play for Lynk's TYK2 inhibitor

Dec 10, 2025 10:27am
Red blood cells and platelets in blood

ASH: Novartis details ianalumab's phase 3 rare blood disease win

Dec 9, 2025 7:30am
Hundred dollar bills flowing out of faucet

Boehringer's deal frenzy continues with $570M autoimmune pact

Nov 4, 2025 8:00am
theatre stage with red curtains

Novartis’ phase 3 wins in Sjögren's see high placebo effect

Oct 29, 2025 12:03pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings